Optimizing Maternal and Neonatal Health: Strategies for Screening, Diagnosing, and Treating Substance Use Disorders in Pregnancy

12pm – 1pm

Click Here or Scan the QR Code to Register

Substance use and substance use disorders in pregnancy are common and linked with multiple obstetric and neonatal adverse outcomes. Ideally, all pregnant patients should be screened, and those with positive screens should be promptly diagnosed and treated to avoid the morbidity and mortality associated with continued substance use during pregnancy. Join us to learn more about evidence-based strategies for identifying and managing patients with substance use during pregnancy.

Learning Objectives:

• Recognize the prevalence of substance use and substance use disorders during pregnancy and identify their association with obstetric and neonatal adverse outcomes.
• Develop a comprehensive understanding of the recommended screening protocols for substance use in pregnant patients to ensure early identification and intervention.
  
• Explore evidence-based treatment strategies and management plans for pregnant patients with substance use disorders to minimize morbidity and mortality risks for both the mother and neonate.

Presenter:

• Alex Peahl, MD, MSc

1 CE Credit Available (1.0 hour):

• CME credit
• MCBAP and Social Work CE credit
• Meets DEA Training Requirements

Who should take this training:

• Healthcare Providers
• Social Workers
• Peer Support
• Mental Health Professionals
• Law Enforcement Professionals